Interleukin-22 Induces Interleukin-18 Expression from Epithelial Cells during Intestinal Infection

Immunity

Volumn 42, Issue 2, 2015, Pages 321-331

  Muñoz, Melba ^a,c   Eidenschenk, Celine ^b   Ota, Naruhisa ^b   Wong, Kit ^b   Lohmann, Uwe ^a   Kühl, Anja A ^a   Wang, Xiaoting ^b   Manzanillo, Paolo ^b   Li, Yun ^b   Rutz, Sascha ^b   Zheng, Yan ^b   Diehl, Lauri ^b   Kayagaki, Nobuhiko ^b   van Lookeren Campagne, Menno ^b   Liesenfeld, Oliver ^a,d   Heimesaat, Markus ^a   Ouyang, Wenjun ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GENENTECH INC   (United States)

^c Leibniz Institute   (Germany)

^d Medical and Scientific Affairs   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 22; MESSENGER RNA; GAMMA INTERFERON; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CITROBACTER RODENTIUM; COLON; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE TARGETING; HOST RESISTANCE; ILEITIS; ILEUM; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTESTINE INFECTION; LAMINA PROPRIA; LUNG; LYMPHOID CELL; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; TOXOPLASMOSIS; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; ENTEROBACTERIACEAE INFECTION; EPITHELIUM CELL; GENETICS; IMMUNOLOGY; INFLAMMATION; INTESTINE MUCOSA; KNOCKOUT MOUSE; MICROBIOLOGY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; ORGAN CULTURE TECHNIQUE; PARASITOLOGY; TH1 CELL; TOXOPLASMA;

ANIMALS; CELLS, CULTURED; CITROBACTER RODENTIUM; ENTEROBACTERIACEAE INFECTIONS; EPITHELIAL CELLS; ILEITIS; ILEUM; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-18; INTERLEUKINS; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; NEUTROPHILS; ORGAN CULTURE TECHNIQUES; RNA, MESSENGER; TH1 CELLS; TOXOPLASMA; TOXOPLASMOSIS; UP-REGULATION;

EID: 84923107393     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2015.01.011     Document Type: Article

References (42)

1. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., Nakanishi K., Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998, 9:143-150.
2. Barton G.M., Medzhitov R. Toll-like receptor signaling pathways. Science 2003, 300:1524-1525.
3. Bennouna S., Bliss S.K., Curiel T.J., Denkers E.Y. Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection. J.Immunol. 2003, 171:6052-6058.
4. Cai G., Kastelein R., Hunter C.A. Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii. Infect. Immun. 2000, 68:6932-6938.
5. Chikano S., Sawada K., Shimoyama T., Kashiwamura S.I., Sugihara A., Sekikawa K., Terada N., Nakanishi K., Okamura H. IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-gamma dependent manner. Gut 2000, 47:779-786.
6. Dao T., Mehal W.Z., Crispe I.N. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J.Immunol. 1998, 161:2217-2222.
7. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 2009, 27:519-550.
8. Egan C.E., Maurer K.J., Cohen S.B., Mack M., Simpson K.W., Denkers E.Y. Synergy between intraepithelial lymphocytes and lamina propria Tcells drives intestinal inflammation during infection. Mucosal Immunol. 2011, 4:658-670.
9. Eidenschenk C., Rutz S., Liesenfeld O., Ouyang W. Role of IL-22 in microbial host defense. Curr. Top. Microbiol. Immunol. 2014, 380:213-236.
10. Elinav E., Strowig T., Kau A.L., Henao-Mejia J., Thaiss C.A., Booth C.J., Peaper D.R., Bertin J., Eisenbarth S.C., Gordon J.I., Flavell R.A. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-757.
11. Ewald S.E., Chavarria-Smith J., Boothroyd J.C. NLRP1 is an inflammasome sensor for Toxoplasma gondii. Infect. Immun. 2014, 82:460-468.
12. Gu Y., Kuida K., Tsutsui H., Ku G., Hsiao K., Fleming M.A., Hayashi N., Higashino K., Okamura H., Nakanishi K., et al. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 1997, 275:206-209.
13. Heimesaat M.M., Bereswill S., Fischer A., Fuchs D., Struck D., Niebergall J., Jahn H.K., Dunay I.R., Moter A., Gescher D.M., et al. Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J.Immunol. 2006, 177:8785-8795.
14. Heimesaat M.M., Fischer A., Siegmund B., Kupz A., Niebergall J., Fuchs D., Jahn H.K., Freudenberg M., Loddenkemper C., Batra A., et al. Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS ONE 2007, 2:e662.
15. Hunter C.A., Subauste C.S., Van Cleave V.H., Remington J.S. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect. Immun. 1994, 62:2818-2824.
16. Kolinska J., Lisa V., Clark J.A., Kozakova H., Zakostelecka M., Khailova L., Sinkora M., Kitanovicova A., Dvorak B. Constitutive expression of IL-18 and IL-18R in differentiated IEC-6 cells: effect of TNF-alpha and IFN-gamma treatment. J.Interferon Cytokine Res. 2008, 28:287-296.
17. Leung B.P., Culshaw S., Gracie J.A., Hunter D., Canetti C.A., Campbell C., Cunha F., Liew F.Y., McInnes I.B. A role for IL-18 in neutrophil activation. J.Immunol. 2001, 167:2879-2886.
18. Liesenfeld O., Kosek J., Remington J.S., Suzuki Y. Association of CD4+ Tcell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J.Exp. Med. 1996, 184:597-607.
19. Liesenfeld O., Kang H., Park D., Nguyen T.A., Parkhe C.V., Watanabe H., Abo T., Sher A., Remington J.S., Suzuki Y. TNF-alpha, nitric oxide and IFN-gamma are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii. Parasite Immunol. 1999, 21:365-376.
20. Mathur A.N., Chang H.C., Zisoulis D.G., Stritesky G.L., Yu Q., O'Malley J.T., Kapur R., Levy D.E., Kansas G.S., Kaplan M.H. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J.Immunol. 2007, 178:4901-4907.
21. Muñoz M., Heimesaat M.M., Danker K., Struck D., Lohmann U., Plickert R., Bereswill S., Fischer A., Dunay I.R., Wolk K., et al. Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J.Exp. Med. 2009, 206:3047-3059.
22. Munoz M., Liesenfeld O., Heimesaat M.M. Immunology of Toxoplasma gondii. Immunol. Rev. 2011, 240:269-285.
23. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 2001, 19:423-474.
24. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., et al. Cloning of a new cytokine that induces IFN-gamma production by Tcells. Nature 1995, 378:88-91.
25. Ouyang W., Rutz S., Crellin N.K., Valdez P.A., Hymowitz S.G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 2011, 29:71-109.
26. Rutz S., Eidenschenk C., Ouyang W. IL-22, not simply a Th17 cytokine. Immunol. Rev. 2013, 252:116-132.
27. Sa S.M., Valdez P.A., Wu J., Jung K., Zhong F., Hall L., Kasman I., Winer J., Modrusan Z., Danilenko D.M., Ouyang W. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J.Immunol. 2007, 178:2229-2240.
28. Sato T., Vries R.G., Snippert H.J., van de Wetering M., Barker N., Stange D.E., van Es J.H., Abo A., Kujala P., Peters P.J., Clevers H. Single Lgr5 stem cells build crypt-villus structures invitro without a mesenchymal niche. Nature 2009, 459:262-265.
29. Sonnenberg G.F., Nair M.G., Kirn T.J., Zaph C., Fouser L.A., Artis D. Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J.Exp. Med. 2010, 207:1293-1305.
30. Sonnenberg G.F., Fouser L.A., Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 2011, 12:383-390.
31. Sonnenberg G.F., Monticelli L.A., Alenghat T., Fung T.C., Hutnick N.A., Kunisawa J., Shibata N., Grunberg S., Sinha R., Zahm A.M., et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 2012, 336:1321-1325.
32. Suzuki Y., Orellana M.A., Schreiber R.D., Remington J.S. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 1988, 240:516-518.
33. Takagi H., Kanai T., Okazawa A., Kishi Y., Sato T., Takaishi H., Inoue N., Ogata H., Iwao Y., Hoshino K., et al. Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice. Scand. J. Gastroenterol. 2003, 38:837-844.
34. Upadhyay V., Poroyko V., Kim T.J., Devkota S., Fu S., Liu D., Tumanov A.V., Koroleva E.P., Deng L., Nagler C., et al. Lymphotoxin regulates commensal responses to enable diet-induced obesity. Nat. Immunol. 2012, 13:947-953.
35. Vossenkämper A., Struck D., Alvarado-Esquivel C., Went T., Takeda K., Akira S., Pfeffer K., Alber G., Lochner M., Förster I., Liesenfeld O. Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii, but IL-12 is dominant over IL-18 in parasite control. Eur. J. Immunol. 2004, 34:3197-3207.
36. Xu D., Chan W.L., Leung B.P., Hunter D., Schulz K., Carter R.W., McInnes I.B., Robinson J.H., Liew F.Y. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J.Exp. Med. 1998, 188:1485-1492.
37. Yang J., Murphy T.L., Ouyang W., Murphy K.M. Induction of interferon-gamma production in Th1 CD4+ Tcells: evidence for two distinct pathways for promoter activation. Eur. J. Immunol. 1999, 29:548-555.
38. Zaki M.H., Boyd K.L., Vogel P., Kastan M.B., Lamkanfi M., Kanneganti T.D. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 2010, 32:379-391.
39. Zenewicz L.A., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., Stevens S., Flavell R.A. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008, 29:947-957.
40. Zenewicz L.A., Yin X., Wang G., Elinav E., Hao L., Zhao L., Flavell R.A. IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. J.Immunol. 2013, 190:5306-5312.
41. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., Ouyang W. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007, 445:648-651.
42. Zheng Y., Valdez P.A., Danilenko D.M., Hu Y., Sa S.M., Gong Q., Abbas A.R., Modrusan Z., Ghilardi N., de Sauvage F.J., Ouyang W. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 2008, 14:282-289.